Manel Fernandez
Sobre mi
After grauating in 2003 as Lab Technician , I have adquired continuated work experience in the field health research. More specifically I am clinical lab tecnhician in neurodegenerative diseases such as Parkinson's disease and atypical parkinsonisms. During these years, I have participated in several competitive European projects as well as in public and private competitive project including clinical trials and I am active member of Parkinson's Progression Marker Initiative (PPMI), the MJFF LRRK2 Cohort Consortium (L2CC) and the International Parkinson's Disease Genomics Consortium (IPDGC). Most of these projects focus on the search for biomarkers for the diagnosis, treatment, or prognosis of neurodegenerative diseases, as well as the underlying etiological processes. From this perspecitve
Publicacions destacades
-
Transcriptome analysis in LRRK2 and idiopathic Parkinson's disease at different glucose levels
Autors:Referència: Npj Parkinsons Dis 2021. -
Cross-sectional associations of cerebrospinal α-synuclein, tau and amyloid-β with dyskinesias, motor fluctuations, non-motor symptoms in a cohort of Parkinson's disease patients
Autors:Referència: Journal Of The Neurological Sciences 2021. -
Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
Autors:Referència: Npj Parkinsons Dis 2021. -
MicroRNADeregulation in Blood Serum Identifies Multiple System Atrophy Altered Pathways
Autors:Referència: Movement Disorders 2020. -
Peripheral insulin and amylin levels in Parkinson's disease
Autors:Referència: Parkinsonism & Related Disorders 2020. -
Transcriptomic differences in MSA clinical variants
Autors:Referència: Scientific Reports 2020.